TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Double Bond Pharmaceutical International AB (publ)
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
123
|
112
|
93 |
Financial expenses |
352
|
0
![]() |
0 |
Earnings before taxes |
-1,563
|
-1,362
|
-905 |
EBITDA |
-1,193
|
-1,345
|
-888 |
Total assets |
1,045
|
1,383
|
2,718 |
Current assets |
452
|
584
|
1,830 |
Current liabilities |
563
|
298
|
382 |
Equity capital |
483
|
1,085
|
2,336 |
- share capital |
430
|
284
|
270 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
46.2%
|
78.5%
|
85.9% |
Turnover per employee |
12
|
11
|
9 |
Profit as a percentage of turnover |
-1270.7%
|
-1216.1%
|
-973.1% |
Return on assets (ROA) |
-115.9%
|
-98.5%
|
-33.3% |
Current ratio |
80.3%
|
196.0%
|
479.1% |
Return on equity (ROE) |
-323.6%
|
-125.5%
|
-38.7% |
Change turnover |
11
|
26
|
-20 |
Change turnover % |
10%
|
30%
|
-18% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.